In-vivo half-life and hypoglycemic bioactivity of a fusion protein of exenatide and elastin-based polypeptide from recombinant Saccharomyces cerevisiae

导出原文传递

翻译打印收藏纠错

作者： Jung, Su Jin ^[1] ; Ngoc-Thanh Thi Nguyen ^[2] ; Lee, Sang Ah ^[2] ; Seo, Sung Hwa ^[1] ; Choi, Eui-Sung ^[3] ; Lee, Hong Weon ^[1] ; Seong, Gi Hun ^[1] ; Bae, Ok Nam ^[1] ; Lee, E. K. ^[2]

作者单位： Hanyang Univ, Grad Sch, Dept Bionanotechnol, Ansan 15588, Gyeonggi Do, South Korea ^[1] KRIBB Ochang Branch Inst, Bio Proc Engn Ctr, Cheongju 28116, Chungcheongbuk, South Korea ^[2] Hanyang Univ, Coll Pharm, Ansan 15588, Gyeonggi Do, South Korea ^[3]

关键词 Exenatide Elastin-based polypeptide (EBP)EBPylation Half-life extension Type 2 diabetes Hypoglycemic efficacy

发布时间 2020-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Biotechnology

2019年303卷

16-24页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

In-vivo half-life and hypoglycemic bioactivity of a fusion protein of exenatide and elastin-based polypeptide from recombinant Saccharomyces cerevisiae

Journal of Biotechnology

相似文献

Journal of Biotechnology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

In-vivo half-life and hypoglycemic bioactivity of a fusion protein of exenatide and elastin-based polypeptide from recombinant Saccharomyces cerevisiae

Journal of Biotechnology

相似文献

Journal of Biotechnology

相关期刊

检索历史清除